Micronised Progesterone Veterinary Injection is a sterile veterinary/clinical progestin depot injectable formulation containing Micronised Progesterone 83.3 mg/ml in an oily vehicle. It is formulated to provide sustained progesterone support and is intended for use in reproductive management and luteal-phase support in livestock and other susceptible animal species, strictly according to the approved product label.

The formulation may be used as part of veterinary reproductive management protocols for estrous cycle synchronization, luteal phase maintenance, and support during threatened or habitual abortion, where specifically indicated for the target species. Micronisation provides a finely divided form of progesterone suitable for incorporation into the injectable oily depot formulation. Administration should be performed strictly by the approved deep intramuscular (IM) route, using the species-specific dose and treatment schedule recommended on the product label.

Active Ingredient Function:
Progesterone is a naturally occurring progestogen that plays an important role in maintaining the reproductive cycle and supporting the uterine environment during the luteal phase and pregnancy. It helps regulate estrous cycling, supports luteal function, and contributes to maintenance of pregnancy where progesterone supplementation is clinically indicated.

Key Features:

Sterile veterinary/clinical progestin depot injection

Contains Micronised Progesterone 83.3 mg/ml

Oil-based depot formulation

Provides sustained progesterone support

May be used in estrous synchronization protocols, where labelled

Supports luteal-phase maintenance

May be indicated for threatened or habitual abortion prevention, where specifically approved

Intended for veterinary reproductive management

Deep intramuscular (IM) administration as directed by the approved label

Composition per vial:

Micronised Progesterone — 83.3 mg/ml

Oily vehicle — q.s.

Dosage form: Sterile injectable depot solution

Important:

This is a veterinary/clinical reproductive therapeutic product intended for use only according to the approved product label and under professional veterinary supervision. Administer strictly by the specified deep intramuscular (IM) route and follow the recommended species-specific dosage and treatment schedule. Do not use in animals with contraindicating conditions such as active pyometra, unexplained/undiagnosed vaginal bleeding, or progesterone-sensitive/neoplastic conditions, unless specifically evaluated and directed by a veterinarian. Pregnancy status and the underlying reproductive condition should be appropriately assessed before treatment. For food-producing animals, strictly observe all applicable regional meat, milk, and other withdrawal requirements specified for the product. Do not use outside the labelled species or indications.